KASHERIA WEST: Open Payments
NPI 1790475325 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 22 payments from 8 companies in 2025. Trend: 2023 $140 · 2024 $597 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $218 |
| ABBVIE INC. | 6 | $140 |
| Axsome Therapeutics, Inc. | 2 | $123 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
Products named: CAPLYTA, VRAYLAR, Auvelity, Qelbree, COBENFY, SPRAVATO, FANAPT, REXULTI.
Industry payments across MD — which companies pay providers there.
